What is the clinical evidence from this study?

Study design: RCT. Population: Stroke or transient ischemic attack (n=160). Intervention: TEAM (TargetEd MAnageMent Intervention) vs. Wait-list control. Primary outcome: Change from baseline to 6 months in systolic blood pressure (SBP).

What question did this study set out to answer?

To evaluate the effectiveness of the TEAM intervention in reducing stroke risk by lowering systolic blood pressure among Black men.

June 16, 2026The International Journal of Aging and Human Development0 citations

View Full Paper

The TargetEd MAnageMent Intervention for Reducing Stroke Risk in Black Men: A 6-Month Prospective Randomized Controlled Trial

MSM SajatovicUniversity Hospitals of Cleveland CSCarolyn StillCase Western Reserve University CBChristopher J. BurantLouis Stokes Cleveland VA Medical Center

Key Result

The TEAM group intervention did not significantly reduce systolic blood pressure at 6 months compared to a wait-list control in Black men with stroke or transient ischemic attack.

Key Points

To evaluate the effectiveness of the TEAM intervention in reducing stroke risk by lowering systolic blood pressure among Black men.
6-month randomized controlled trial with 160 participants, N=78 in TEAM, N=82 in Waitlist.
Primary outcome measured was change in systolic blood pressure from baseline.
Attrition rate was 53.1%, comparable across both intervention and control groups.
Post-intervention systolic blood pressure decreased numerically in the entire sample but not statistically significantly.
No significant difference in systolic blood pressure reduction between TEAM and Waitlist groups.
Subgroup analyses indicated significant blood pressure reduction in individuals with elevated baseline pressure in the TEAM group.

Study Design

Type

RCT (n=160)

Randomization

randomized

Structured PICO

Does a group intervention (TEAM) reduce systolic blood pressure in Black men with prior stroke or transient ischemic attack?

Population

160 Black men with stroke or transient ischemic attack, mean age 61.2 years, followed for 6 months.

Intervention

TEAM, a 6-month group intervention to reduce stroke risk

Comparator

6-month wait-list control

Outcome

Change from baseline to 6 months in systolic blood pressure (SBP)surrogate

A 6-month group intervention did not significantly reduce systolic blood pressure compared to a wait-list control in Black men with prior stroke or TIA, though post-hoc analyses suggested potential benefit in those with elevated baseline BP.

Limitations

Attrition was 53.1%

Abstract

This 6-month randomized controlled trial compared TEAM, a group intervention to reduce stroke risk versus a 6-month wait-list control in Black men with stroke or transient ischemic attack. The primary outcome was the change from baseline to 6 months in systolic blood pressure (SBP). There were 160 randomized, N = 78 to TEAM, N = 82 to Waitlist, mean age 61.2 ( SD 9.5). Attrition was 53.1% and similar across arms. Biomarker values were extracted from health records for individuals with missed visits. Baseline SBP was 135.3 ( SD 17.9). Among the entire sample, SBP was numerically but not statistically significantly reduced with no significant difference between TEAM versus Waitlist. Post-hoc analyses suggested those with elevated baseline blood pressure (BP) had significant BP reduction in the group as a whole and in TEAM. Future research might target Black men with poorly controlled BP and address barriers to engaging in risk reduction programs.

Ask AI

Helpful

Bookmark

View Full Paper

Ask AI

Helpful

Bookmark

View Full Paper

The TargetEd MAnageMent Intervention for Reducing Stroke Risk in Black Men: A 6-Month Prospective Randomized Controlled Trial

Key Result

Key Points

Study Design

Structured PICO

Limitations

Abstract

Cite This Study

Also Consider

Also Consider